BOCT vs YMAG
Innovator U.S. Equity Buffer ETF - October vs YieldMax Magnificent 7 Fund of Option Income ETF
Which is better, BOCT or YMAG?
Each has led over a different period.
BOCT has a lower expense ratio. BOCT led over 1Y, YMAG over the full window.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | BOCT | YMAG |
|---|---|---|
| Expense Ratio | 0.79%Best | 1.34% |
| AUM | $307M | $294M |
| Dividend Yield | 0.00% | 57.01% |
| Holdings | 18 | 18 |
| YTD Return | +12.12%Best | +9.90% |
| 1Y Return | +15.15%Best | +13.88% |
| 3Y Return (annualized) | +15.46% | - |
| 5Y Return (annualized) | +10.73% | - |
| Volatility (annualized) | 7.4%Best | 17.4% |
| Max Drawdown | -13.6%Best | -26.0% |
| $10,000 over 2.7 years | $14,106 | $17,580Best |
| Fund Family | Innovator ETFs Trust | YieldMax ETF |
| Category | Alternative | Alternative |
| Style | Option Writing | Option Writing |
| Inception | Sep 28, 2018 | Jan 29, 2024 |
Not shown on this pair: Top 10 Weight.
Volatility and max drawdown, and the $10,000 over 2.7 years row, are measured over the window both funds cover: Jan 30, 2024 to Oct 14, 2026 (2.7 years).
BOCT vs YMAG growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 2.7 years both funds cover.
BOCT vs YMAG Performance
Innovator U.S. Equity Buffer ETF - October (BOCT) is an ETF from Innovator ETFs Trust and YieldMax Magnificent 7 Fund of Option Income ETF (YMAG) is an ETF from YieldMax ETF. Over the past year BOCT returned +15.15% while YMAG returned +13.88%. Year to date, BOCT is up 12.12% versus a gain of 9.90% for YMAG.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
YMAG has been the more volatile fund, with annualized monthly volatility of 17.4% compared with 7.4% for BOCT. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -13.6% for BOCT and -26.0% for YMAG. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.81. They usually move together, but the gap leaves some room for diversification.
Fees and Cost Over Time
BOCT charges 0.79% per year while YMAG charges 1.34%. On a $10,000 position that is $79 vs $134 annually, a gap of $55 per year that compounds over a long holding period. On income, BOCT currently yields 0.00% against 57.01% for YMAG.
You are not choosing between two funds in isolation.
Whichever of BOCT and YMAG you pick has to sit alongside everything else you own. Add the rest and see what the combination actually holds.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, BOCT or YMAG?
BOCT has an expense ratio of 0.79% while YMAG charges 1.34%. BOCT is the cheaper option, by $55 a year on a $10,000 investment.
Which performed better, BOCT or YMAG?
Over the past year BOCT returned +15.15% vs +13.88% for YMAG, so BOCT leads on 1-year performance. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, BOCT or YMAG?
YMAG has been the more volatile fund at 17.4% annualized versus 7.4% for BOCT. Worst drawdown: BOCT -13.6% vs YMAG -26.0%.
Should I hold both BOCT and YMAG?
BOCT and YMAG have a monthly-return correlation of 0.81, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
Which pays a higher dividend, BOCT or YMAG?
BOCT yields 0.00% while YMAG yields 57.01%, so YMAG currently pays the higher dividend yield.
Is YMAG better than BOCT?
BOCT has a lower expense ratio. BOCT led over 1Y, YMAG over the full window. Which one suits a particular account depends on what it is for. This is information, not a recommendation.